Clinical Assistant Professor, Department of Medicine
Biosketch
Mazen Mislmani, MD is a physician at West Michigan Cancer Center. Dr. Mislmani earned his medical degree in 2010 from Wayne State University School of Medicine. He went on to complete a radiation oncology residency in 2015 from Seidman Cancer Center/Case Western Reserve University in Cleveland, OH.
-
Board Certification
- American Board of Radiology (Radiation Oncology)
-
Education and Training
- Residency 2015, Radiation Oncology, Seidman Cancer Center, Case Western Reserve University
- Internship 2011, Family Medicine, Crittenton Hospital, Wayne State University
- MD 2010, School of Medicine, Wayne State University
- BS 2004, Radiation Therapy, Magna Cum Laude, Wayne State University School of Medicine,
-
Research
- Radiation Oncology
-
Publications
Chen A.Y., Sassic J.K., Mislmani M., Hoekstra A.V. High-dose palliative radiation therapy for solitary recurrence of ovarian cancer in the brain: A case report Journal of Reproductive Medicine. 2020;65:320-324.
Awan M.J., Dorth J., Mani A., Kim H., Zheng Y., Mislmani M., Welford S., Yuan J., Wessels B.W., Lo S.S., Letterio J., Machtay M., Sloan A., Sohn J.W. Development and Validation of a Small Animal Immobilizer and Positioning System for the Study of Delivery of Intracranial and Extracranial Radiotherapy Using the Gamma Knife System Technology in Cancer Research and Treatment. 2017;16(2):203-210.
Brett-Morris A., Mislmani M., Welford S.M. SAT1 and glioblastoma multiforme: Disarming the resistance Molecular and Cellular Oncology. 2015;2(3)
Kunos C.A., Sherertz T.M., Mislmani M., Ellis R.J., Lo S.S., Waggoner S.E., Zanotti K.M., Herrmann K., Debernardo R.L. Phase I trial of carboplatin and gemcitabine chemotherapy and stereotactic ablative radiosurgery for the palliative treatment of persistent or recurrent gynecologic cancer Frontiers in Oncology. 2015;5(JUN)
Mislmani M., Frasure H., Suppiah S., Fabien J., Lo S., Debernardo R., Kunos C. Acute gastrointestinal toxicity after robotic stereotactic ablative radiotherapy for treatment of metastatic gynecological malignancies Future Oncology. 2014;10(2):241-248.